Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 48 non-cytoplasmic 49 68 transmembrane 69 80 cytoplasmic 81 100 transmembrane 101 106 non-cytoplasmic 107 131 transmembrane 132 141 cytoplasmic 142 162 transmembrane 163 173 non-cytoplasmic 174 196 transmembrane 197 239 cytoplasmic 240 262 transmembrane 263 273 non-cytoplasmic 274 297 transmembrane 298 308 cytoplasmic 309 327 transmembrane 328 332 non-cytoplasmic 333 352 transmembrane 353 360 cytoplasmic 361 385 transmembrane 386 396 non-cytoplasmic 397 417 transmembrane 418 431 cytoplasmic
Input: >Pf6N2E2_1105 MKTLPVSVLAKISWRLLPFLLLMYIMAFLDRANVGFAKQAFQADTGIGDAAFAFGAGVFF AGYALLEVPSNLILHRVGARLWMCRIMVTWGLVSAAMVFAHNETSFYVLRFLLGVAEAGF FPGVILYLTYWFPSAARGKAMGFFYFGAPLAFIFGSPLSGLLLELDGFAGVHGWQWLFAV EGLMASAVGIWAYWYLDNRPADAKWLTVEERRQVQSLLDAEDQHKQSHGRSLLSVLCQPS VLYLCLIYLLIQASVYGVVFYLPTQVGGLLGSKVGLMVGLVTAIPWICALCAAYLIPGYS DRTGQRRRTAALTLLMAAAGIACSVSVSSPLLGIIALCFAASGFIAVQPVFWTFPSSYLA GSAAAAGIALINSFGALGGFIAPVLKNWAEGAFHSPAAGLYLLSVTTVIAALLVLGIHSP GQRASKTPATV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server